瑞加诺生负荷门控SPECT心肌灌注显像后左心室射血分数下降的意义
本研究分析连续接受静息/瑞加诺生负荷门控SPECT心肌灌注显像后6个月内行冠状动脉造影的患者。诊断队列793例中,左心室射血分数变化不能预测严重/广泛冠状动脉疾病(AUC 0.50,95%CI 0.44-0.57,P=0.946);结局队列929例随访30±16个月,负荷后左心室射血分数下降与心脏死亡或心肌梗死复合终点及血运重建风险无关。
要点
- 瑞加诺生负荷后LVEF下降不能预测严重/广泛冠状动脉疾病(AUC 0.50)。
- 无论MPI结果如何,LVEF下降与否的严重/广泛CAD发生率无显著差异。
- 随访30±16个月,负荷后LVEF下降与心脏死亡/心肌梗死或血运重建风险无关。
核心结论
- 在瑞加诺生负荷门控SPECT心肌灌注显像后接受冠状动脉造影的患者中,负荷后左心室射血分数下降不能预测严重/广泛冠状动脉疾病或不良临床结局,无论MPI结果如何。
研究设计与样本
- 连续纳入接受静息/瑞加诺生负荷门控SPECT心肌灌注显像后6个月内行冠状动脉造影的患者。
- 诊断队列793例受试者,计算左心室射血分数变化为负荷左心室射血分数减静息左心室射血分数,并以5%和10%阈值检验显著下降。
- 结局队列929例受试者,随访30±16个月。
主要发现
- 诊断队列793例中,左心室射血分数变化不能预测严重/广泛冠状动脉疾病(曲线下面积0.50,95%CI 0.44-0.57,P=0.946)。
- 无论MPI结果如何,有或无左心室射血分数下降患者的严重/广泛冠状动脉疾病发生率无显著差异。
- 结局队列929例随访30±16个月,瑞加诺生负荷后左心室射血分数下降与心脏死亡或心肌梗死复合终点风险增加无关,与冠状动脉血运重建风险也无关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The significance of post-stress decrease in left ventricular ejection fraction (LVEF) with regadenoson stress gated SPECT (GSPECT) myocardial perfusion imaging (MPI) has not been studied. METHODS AND RESULTS: Consecutive patients who underwent rest/regadenoson stress GSPECT-MPI followed by coronary angiography within 6 months were analyzed. Change in LVEF by GSPECT-MPI was calculated as stress LVEF minus rest LVEF; a significant decrease was tested at 5% and 10% thresholds. In a diagnostic cohort of 793 subjects, LVEF change was not predictive of severe/extensive coronary artery disease (area under the curve, 0.50; 95% confidence interval, 0.44-0.57; P = 0.946). There was no significant difference in the rates of severe/extensive coronary artery disease in patients with or without a decrease in LVEF, irrespective of MPI findings. In an outcome cohort of the 929 subjects followed for 30 ± 16 months, post-regadenoson stress decrease in LVEF was not associated with increased risk of the composite endpoint of cardiac death or myocardial infarction or in the risk of coronary revascularization. CONCLUSIONS: In patients selected to undergo coronary angiography following regadenoson stress GSPECT-MPI, a decrease in LVEF after regadenoson stress is not predictive of severe/extensive CAD or adverse clinical outcomes, irrespective of MPI findings.
引用
- Gomez J, Golzar Y, Fughhi I, et al. The significance of post-stress decrease in left ventricular ejection fraction in patients undergoing regadenoson stress gated SPECT myocardial perfusion imaging. J Nucl Cardiol. 2017. PMID: 28181156. doi:10.1007/s12350-017-0802-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。